FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.91, $0.20 better than the analyst estimate of $0.71. Revenue for the quarter came in at $207.6 million versus the consensus estimate of $189.6 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.13-$3.20, versus the consensus of $3.09. Repligen sees... More

